Share
Title
COVID-19 variants (CME)
Code
SY54
Session Type
Symposium
Track
Not applicable
Channel
Berlin+
Date Time
21 July 12:00- 12:50
Local Date Time
12:00 - 12:50 W. Europe Daylight Time
Moderator:
Sharon LEWIN, University of Melbourne, Australia

The purpose of this session is to provide the latest information on the virology and clinical and population impact of new SARS CoV2 variants of concerns. Our speakers will discuss the impact of the variants on natural history, pathogenesis and transmission. In addition they will discuss the effect of new variants on efficacy of monoclonal antibodies and vaccination. Future strategies to detect, monitor and prevent the emergence of new variants will also be discussed.

2 min
 Introduction
Sharon LEWIN, University of Melbourne, Australia

10 min
 Virology/structural biology of variants
Paul BIENIASZ, Rockefeller University, United States
Word
PDF
10 min
 Diagnosis, epidemiology and spread
Ester C. SABINO, University of São Paulo, Brazil
Slides
10 min
 Impact on treatments and vaccines
Olivier SCHWARTZ, Institut Pasteur, France
18 min
 Live panel discussion
Paul BIENIASZ, Rockefeller University, United States
Ester C. SABINO, University of São Paulo, Brazil
Olivier SCHWARTZ, Institut Pasteur, France
Sharon LEWIN, University of Melbourne, Australia
Word